The absurdities of Hollywood and the forces that shape its narrative have once again taken center stage with the ongoing fallout from Alec Baldwin’s involuntary manslaughter case regarding the tragic shooting of cinematographer Halyna Hutchins. While Baldwin’s legal battle appeared to have come to a resolution in July 2023 when the case was dismissed, the
0 Comments
The Federal Trade Commission (FTC) has taken a significant step by filing a lawsuit against three dominant pharmacy benefit managers (PBMs), namely Caremark, Express Scripts, and OptumRx. This lawsuit sheds light on the controversial role these entities play in the skyrocketing costs of essential medications, particularly insulin, which is vital for millions of Americans living
0 Comments
Two decades have passed since the landmark study published in the journal Science first introduced the term “microplastics” to the scientific community and the general public. As we reflect on the journey of research and understanding regarding these tiny plastic particles, it’s important to evaluate what has been gleaned from years of study. Microplastics—particles measuring
0 Comments
Recent testimonies surrounding the late Mohamed Al Fayed, former owner of the prestigious Harrods department store, depict a harrowing narrative of alleged abuse and exploitation. Characterized as a “predator” by one of his alleged victims, the revelations have ignited a broader discussion about systemic failings within corporate structures designed to protect employees. The claims made
0 Comments